CAR-NK (Oncoinsight)

N/A

Report date: 2025/03/14 16:40:08

Base Information

Drug NameCAR-NK (Oncoinsight)
Drug Alias NameCAR NK-cell therapy (Oncoinsight)CAR-NK
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy
Mechanisms of ActionImmunostimulantsNatural killer cells stimulants
TargetsUpdating
Therapy Area/IndicationsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncoinsight Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOncoinsight Co Ltd
Inactive CompaniesN/A
Active IndicationsStomach Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A